CRISPR Therapeutics

A leading gene editing company that focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. This technology allows for precise, directed changes to genomic DNA, making it a revolutionary tool in the field of gene editing, setting it apart from traditional genetic modification methods. CRISPR Therapeutics primarily targets patients suffering from genetic disorders and other serious diseases, offering potential cures and treatments through advanced gene editing techniques.

CRISPR Therapeutics was discovered on December 30th 2022 and it currently has a search volume of 18.1K with a growth of +400%.